AU2023249151A1 - Live mycoplasma gallisepticum vaccines - Google Patents

Live mycoplasma gallisepticum vaccines Download PDF

Info

Publication number
AU2023249151A1
AU2023249151A1 AU2023249151A AU2023249151A AU2023249151A1 AU 2023249151 A1 AU2023249151 A1 AU 2023249151A1 AU 2023249151 A AU2023249151 A AU 2023249151A AU 2023249151 A AU2023249151 A AU 2023249151A AU 2023249151 A1 AU2023249151 A1 AU 2023249151A1
Authority
AU
Australia
Prior art keywords
mycoplasma gallisepticum
vaccine
strain
composition
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023249151A
Other languages
English (en)
Inventor
Naola M. FERGUSON-NOEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc
Original Assignee
University of Georgia
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia, University of Georgia Research Foundation Inc filed Critical University of Georgia
Publication of AU2023249151A1 publication Critical patent/AU2023249151A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU2023249151A 2022-04-06 2023-04-05 Live mycoplasma gallisepticum vaccines Pending AU2023249151A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263327851P 2022-04-06 2022-04-06
US63/327,851 2022-04-06
US202263404226P 2022-09-07 2022-09-07
US63/404,226 2022-09-07
PCT/US2023/017527 WO2023196374A1 (en) 2022-04-06 2023-04-05 Live mycoplasma gallisepticum vaccines

Publications (1)

Publication Number Publication Date
AU2023249151A1 true AU2023249151A1 (en) 2024-09-19

Family

ID=88243428

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023249151A Pending AU2023249151A1 (en) 2022-04-06 2023-04-05 Live mycoplasma gallisepticum vaccines

Country Status (7)

Country Link
US (1) US20250235521A1 (https=)
EP (1) EP4504902A4 (https=)
JP (1) JP2025510684A (https=)
CN (1) CN119816588A (https=)
AU (1) AU2023249151A1 (https=)
MX (1) MX2024011270A (https=)
WO (1) WO2023196374A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117434281B (zh) * 2023-10-18 2026-01-06 上海太阳生物技术有限公司 组合物、检测试剂、检测试剂盒以及在制备检测凝血因子x活性中的应用
CN118078972B (zh) * 2024-03-07 2024-10-22 佛山大学 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用
CN117965308B (zh) * 2024-03-07 2024-09-13 佛山科学技术学院 一种鹅源鸡毒支原体及其分离、鉴定方法和应用
CN119552994B (zh) * 2025-01-17 2025-11-14 广西壮族自治区动物疫病预防控制中心(广西壮族自治区屠宰技术中心) 鉴别鸡毒支原体野毒株和疫苗株的四重荧光pcr引物探针组合、反应体系、方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187162A1 (en) * 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
MX2011007732A (es) * 2009-01-22 2011-11-04 Univ Georgia Formulacion de mycoplasma gallisepticum.
EP3391903B1 (en) * 2017-04-21 2022-02-23 The Pirbright Institute Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens

Also Published As

Publication number Publication date
US20250235521A1 (en) 2025-07-24
WO2023196374A1 (en) 2023-10-12
EP4504902A4 (en) 2026-05-06
EP4504902A1 (en) 2025-02-12
JP2025510684A (ja) 2025-04-15
MX2024011270A (es) 2024-09-25
CN119816588A (zh) 2025-04-11

Similar Documents

Publication Publication Date Title
Ley et al. Mycoplasma gallisepticum infection
EP4504902A1 (en) Live mycoplasma gallisepticum vaccines
CN103347534B (zh) 牛病毒性腹泻病毒1b型疫苗组合物和方法
CN102458462B (zh) 一种温度敏感的猪肺炎支原体疫苗株及其应用
US8668912B2 (en) Mycoplasma gallisepticum formulation
CN110545839A (zh) 牛呼吸道疾病疫苗
US7217420B2 (en) Mycoplasma gallisepticum formulation
US20250186512A1 (en) Live mycoplasma synoviae vaccine
US8563005B2 (en) Actinobacillus suis antigens
US6605460B1 (en) Avian pneumovirus vaccine
Assefa Inactivated Vaccine Trial of Mycoplasma gallisepticum in Ethiopia
US20030149255A1 (en) Bird diagnostics and treatments
HK1161289B (en) Mycoplasma gallisepticum formulation